Atlas Trials

Interventional Software for Multi-immunotherapy of Solid Tumors

Clinical trial NCT06478108 · RECRUITING

Trial details

NCT number
NCT06478108
Sponsor
Second Affiliated Hospital of Guangzhou Medical University
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Lung CancerLiver CancerSolid Tumor, Adult
Start date
2024-04-01
Primary completion
2028-12-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.